1215156

R. Doyle Stulting, MD — FEI 3010543346

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
755221 CFR 312.66Changes in research
762921 CFR 312.56(c)Annual report